mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-07 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
5e-07 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-07 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
1e-06 |